Logo-apb
Adv Pharm Bull. 2020;10(2): 264-270. doi: 10.34172/apb.2020.031
PMID: 32373495        PMCID: PMC7191242

Research Article

Helicobacter pylori Recombinant CagA Regulates Th1/Th2 Balance in a BALB/c Murine Model

Nafiseh Paydarnia 1,2, Behzad Mansoori 1,3 ORCID, Davoud Esmaeili 4, Tohid Kazemi 1 ORCID, Mahyar Aghapour 5 ORCID, Khalil Hajiasgharzadeh 1, Nazila Alizadeh 1, Behzad Baradaran 1 * ORCID

Cited by CrossRef: 12


1- Ranjbariyan A, Haghighat S, Yazdi M, Arbabi Bidgoli S. Synthetic selenium nanoparticles as co-adjuvant improved immune responses against methicillin-resistant Staphylococcus aureus. World J Microbiol Biotechnol. 2023;39(1) [Crossref]
2- Lu Y, Ning H, Kang J, Bai G, Zhou L, Kang Y, Wu Z, Tian M, Zhao J, Ma Y, Bai Y. Cyclic-di-AMP Phosphodiesterase Elicits Protective Immune Responses Against Mycobacterium tuberculosis H37Ra Infection in Mice. Front Cell Infect Microbiol. 2022;12 [Crossref]
3- Atrisco-Morales J, Ramírez M, Castañón-Sánchez C, Román-Román A, Román-Fernández I, Martínez-Carrillo D, García-Arellano S, Muñoz-Valle J, Rodríguez-Ruiz H, Fernández-Tilapa G. In Peripheral Blood Mononuclear Cells Helicobacter pylori Induces the Secretion of Soluble and Exosomal Cytokines Related to Carcinogenesis. IJMS. 2022;23(15):8801 [Crossref]
4- Portillo-Miño J, Bettin-Gonzalez D, Coral F. mRNA vaccines in gastric cancer: How close are we?. Vacunas. 2024;25(1):88 [Crossref]
5- Portillo-Miño J, Bettin-Gonzalez D, Coral F. mRNA vaccines in gastric cancer: How close are we?. Vacunas (English Edition). 2024;25(1):88 [Crossref]
6- Nian X, Zhang J, Deng T, Liu J, Gong Z, Lv C, Yao L, Li J, Huang S, Yang X. AddaVax Formulated with PolyI:C as a Potential Adjuvant of MDCK-based Influenza Vaccine Enhances Local, Cellular, and Antibody Protective Immune Response in Mice. AAPS PharmSciTech. 2021;22(8) [Crossref]
7- Zhang Y, Li X, Shan B, Zhang H, Zhao L. Perspectives from recent advances of Helicobacter pylori vaccines research. Helicobacter. 2022;27(6) [Crossref]
8- Fan J, Zhu J, Xu H. Strategies of Helicobacter pylori in evading host innate and adaptive immunity: insights and prospects for therapeutic targeting. Front Cell Infect Microbiol. 2024;14 [Crossref]
9- Li S, Zhao W, Xia L, Kong L, Yang L. How Long Will It Take to Launch an Effective Helicobacter pylori Vaccine for Humans?. IDR. 2023;Volume 16:3787 [Crossref]
10- Qin D, Wang L, Ni Y, Shan Z, Yang L. Knowledge, Attitude, and Practice of the Gastroenterology Department Patients Towards Chronic Gastritis in Shanxi Region: A Cross-Sectional Study. PPA. 2024;Volume 18:1769 [Crossref]
11- Zhang Z, Cui M, Ji X, Su G, Zhang Y, Du L. Candidate Antigens and the Development of Helicobacter pylori Vaccines. Helicobacter. 2024;29(4) [Crossref]